A 27-bp deletion from one allele of the type III collagen gene (COL3A1) in a large family with Ehlers-Danlos syndrome type IV
- PMID: 1370809
- DOI: 10.1007/BF00197268
A 27-bp deletion from one allele of the type III collagen gene (COL3A1) in a large family with Ehlers-Danlos syndrome type IV
Abstract
A large family with Ehlers-Danlos syndrome type IV (EDS IV) has previously been described. Unlike most cases of EDS IV, fibroblasts from affected members secreted near normal amounts of type III collagen. We have localized the mutation in this family to the CB5 peptide of type III collagen, by using both protein and cDNA mapping techniques. Sequence analysis of cDNA revealed a 27-bp deletion within exon 37, a deletion that removed nine amino acids and maintained the Gly-X-Y repeat of the collagen helix. Further sequencing of genomic DNA confirmed its location, and amplification of DNA from family members showed that it was absent in unaffected individuals but present in all the affected individuals tested. This deletion is flanked by two short direct repeats of CTCC; it may have arisen by slipped mispairing, and has subsequently been transmitted to all affected family members.
Similar articles
-
A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV.J Biol Chem. 1990 Oct 5;265(28):17070-7. J Biol Chem. 1990. PMID: 2145268
-
Abnormal type III collagen produced by an exon-17-skipping mutation of the COL3A1 gene in Ehlers-Danlos syndrome type IV is not incorporated into the extracellular matrix.Biochem J. 1995 Nov 1;311 ( Pt 3)(Pt 3):939-43. doi: 10.1042/bj3110939. Biochem J. 1995. PMID: 7487954 Free PMC article.
-
A single base mutation in the gene for type III collagen (COL3A1) converts glycine 847 to glutamic acid in a family with Ehlers-Danlos syndrome type IV. An unaffected family member is mosaic for the mutation.Hum Genet. 1992 Jun;89(4):414-8. doi: 10.1007/BF00194313. Hum Genet. 1992. PMID: 1352273
-
[Ehlers-Danlos syndromes. Clinical, genetic and molecular aspects].Ann Dermatol Venereol. 1995;122(4):187-204. Ann Dermatol Venereol. 1995. PMID: 8526413 Review. French.
-
The Ehlers-Danlos syndromes.Semin Dermatol. 1993 Sep;12(3):229-40. Semin Dermatol. 1993. PMID: 8217561 Review.
Cited by
-
Ehlers-Danlos syndrome type IV.Orphanet J Rare Dis. 2007 Jul 19;2:32. doi: 10.1186/1750-1172-2-32. Orphanet J Rare Dis. 2007. PMID: 17640391 Free PMC article. Review.
-
The substitution of glycine 661 by arginine in type III collagen produces mutant molecules with different thermal stabilities and causes Ehlers-Danlos syndrome type IV.J Med Genet. 1993 Aug;30(8):690-3. doi: 10.1136/jmg.30.8.690. J Med Genet. 1993. PMID: 8411057 Free PMC article.
-
Ehlers-Danlos syndrome has varied molecular mechanisms.J Med Genet. 1997 May;34(5):400-10. doi: 10.1136/jmg.34.5.400. J Med Genet. 1997. PMID: 9152838 Free PMC article. Review. No abstract available.
-
Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus.Am J Hum Genet. 1994 Aug;55(2):266-77. Am J Hum Genet. 1994. PMID: 7913579 Free PMC article.
-
Spontaneous hemo-pneumothorax in a patient with Ehlers-Danlos syndrome.Gen Thorac Cardiovasc Surg. 2012 Sep;60(9):587-9. doi: 10.1007/s11748-012-0047-x. Epub 2012 May 19. Gen Thorac Cardiovasc Surg. 2012. PMID: 22610159
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Medical
Molecular Biology Databases
Miscellaneous